Le malattie rare sono rare, ma le persone
affette sono tante

Partnership : Accademici = , Industria = , Investitori finanziari =

• • AUSTRIA
  • WIEN
  • WIEN
  • DIRECT: disseminate research funded by EC improving treatment options for children suffering from cancer (coordination)
  • St. Anna Kinderkrebsforschung e.V.
  • CCRI - Children's Cancer Research Institute
  • Ulteriori dettagli
• • FRANCIA
  • ILE-DE-FRANCE
  • ORSAY
  • DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
  • Université Paris-Sud XI
  • Institut de Chimie Moléculaire et des Matériaux d'Orsay
  • Ulteriori dettagli
• • FRANCIA
  • ILE-DE-FRANCE
  • VILLEJUIF
  • O3K: oral off-patent oncology drugs for kids (coordination)
  • CRLCC Institut de cancérologie Gustave Roussy
  • Département de cancérologie de l'enfant et de l'adolescent
  • Ulteriori dettagli
• • FRANCIA
  • RHONE-ALPES
  • LYON
  • French-speaking evaluation, combination therapy and survey for ovarian germ cell tumors, granulosa cell tumors and other stromal malignacies of adults
  • CRLCC Léon Bérard
  • Département de médecine carcinologique
  • Ulteriori dettagli
• • FRANCIA
  • RHONE-ALPES
  • LYON
  • Protocol of healthcare of adult ovarian germ cell malignant tumor
  • CRLCC Léon Bérard
  • Département de médecine carcinologique
  • Ulteriori dettagli
• • ITALIA
  • EMILIA ROMAGNA
  • MODENA
  • LIGHTS: Studio di ligandi del dimero Thymidylate come nuovo strumento per lo sviluppo di agenti antitumorali contro il carcinoma ovarico
  • Università degli Studi di Modena e Reggio Emilia
  • Dipartimento di Scienze Farmaceutiche
  • Ulteriori dettagli
• • ITALIA
  • LOMBARDIA
  • MILANO
  • RARECARE: surveillance of rare cancers in Europe (coordination)
  • Fondazione IRCCS Istituto Nazionale dei Tumori
  • S.S. di Epidemiologia Valutativa
  • Ulteriori dettagli
• • PORTOGALLO
  • NORTE
  • PORTO
  • Integrated Micro-Nano-OPTO Fluidic systems for high-content diagnosis and studies of rare cancer cells
  • Instituto de Patologia e Imunologia Molecular da Universidade do Porto
  • Genética de Tumores
  • Ulteriori dettagli
• • REGNO UNITO; GRAN BRETAGNA
  • Tyne & Wear
  • NEWCASTLE UPON TYNE
  • EPOC: European paediatric oncology off-patent medicines consortium (coordination)
  • Newcastle University
  • Northern Institute for Cancer Research
  • Ulteriori dettagli
• • SPAGNA
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Identification of new therapeutic targets in refractory germinal tumors
  • ICO L'Hospitalet
  • Grupo de Angiogénesis
  • Ulteriori dettagli
• • SPAGNA
  • Madrid
  • MADRID
  • Determination of genetic pathways that contribute to the origin and development of familial and sporadic ovarian cancer. Search for prognostic markers and design of molecular classifiers based on high-resolution CGH profiles
  • Centro Nacional de Investigaciones Oncológicas (CNIO)
  • Grupo de Genética Humana
  • Ulteriori dettagli